Related Experiment Video
Updated: Dec 29, 2025

09:19
Contrast Enhanced Ultrasound Imaging for Assessment of Spinal Cord Blood Flow in Experimental Spinal Cord Injury
Published on: May 7, 2015
14.4K
Interventions to Optimize Spinal Cord Perfusion in Patients with Acute Traumatic Spinal Cord Injuries: A Systematic
Nathan Evaniew1,2, Shahriar J Mazlouman3, Emilie P Belley-Côté4
1Vancouver Spine Surgery Institute (VSSI), Department of Orthopaedics, University of British Columbia, Vancouver, British Columbia, Canada.
Journal of Neurotrauma
|February 7, 2020
Summary
Optimizing spinal cord perfusion pressure (SCPP) may aid neurological recovery after traumatic spinal cord injury (SCI), but evidence is limited. Current interventions lack clear efficacy and safety data, necessitating further research.
Area of Science:
- Neuroscience
- Traumatology
- Critical Care Medicine
Background:
- Optimizing spinal cord perfusion pressure (SCPP) is crucial for managing acute traumatic spinal cord injuries (SCI).
- Current interventions supporting mean arterial pressure (MAP) or SCPP face controversy regarding efficacy and safety.
- Neurological recovery and adverse event risks associated with these interventions require thorough investigation.
Purpose of the Study:
- To determine the effects of optimizing spinal cord perfusion on neurological recovery in acute traumatic SCI patients.
- To assess the risks of adverse events associated with interventions aimed at supporting MAP or SCPP.
- To synthesize current evidence on the efficacy and safety of spinal cord perfusion optimization strategies.
Main Methods:
- Systematic literature search across multiple databases for published and unpublished reports.
- Independent screening, data extraction, and risk of bias assessment by two reviewers.
- Data synthesis and confidence evaluation using the GRADE approach.
Main Results:
- Low to very low quality evidence indicates uncertain effects of MAP support on neurological recovery.
- Vasopressor use for MAP support may increase cardiac adverse events.
- Increased SCPP potentially linked to improved recovery, but monitoring carries risks like CSF leakage.
- Limited comparative data exists for specific MAP/SCPP goals or monitoring techniques.
- Norepinephrine may have fewer adverse events than dopamine, based on very low-quality evidence.
Conclusions:
- Current literature provides insufficient evidence for strong recommendations on MAP or SCPP support in acute traumatic SCI.
- Individualized treatment approaches may be optimal given the data limitations.
- Further research is warranted to clarify the risks, benefits, and alternatives for spinal cord perfusion support in SCI patients.

